MEDP Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | Kraft Robert O. | director | 448 | M-Exempt | A | 72 | 0.00 | 0.00 |
| 2024-03-31 | Kraft Robert O. | director | 214 | M-Exempt | D | 72 | 0.00 | 0.00 |
| 2024-03-31 | McCarthy Cornelius P. III | director | 5,101 | M-Exempt | A | 63 | 0.00 | 0.00 |
| 2024-03-31 | McCarthy Cornelius P. III | director | 186 | M-Exempt | D | 63 | 0.00 | 0.00 |
| 2024-03-31 | Carley Brian T | director | 21,674 | M-Exempt | A | 79 | 0.00 | 0.00 |
| 2024-03-31 | Carley Brian T | director | 234 | M-Exempt | D | 79 | 0.00 | 0.00 |
| 2024-03-15 | BURWIG SUSAN E | officer: Exec. VP, Operations | 15,181 | S-Sale | D | 102 | 403.00 | 41,106.00 |
| 2024-03-14 | Keating Ashley M. | director | 3,358 | M-Exempt | D | 500 | 84.36 | 42,180.00 |
| 2024-03-14 | Keating Ashley M. | director | 500 | M-Exempt | A | 500 | 84.36 | 42,180.00 |
| 2024-03-14 | Keating Ashley M. | director | 250 | S-Sale | D | 250 | 409.87 | 102,468.00 |
| 2024-03-06 | Troendle August J. | director, 10 percent owner, officer: CEO | 4,833,019 | S-Sale | D | 100,000 | 412.98 | 41,298,000.00 |
| 2024-03-07 | Troendle August J. | director, 10 percent owner, officer: CEO | 4,758,019 | S-Sale | D | 75,000 | 410.74 | 30,805,500.00 |
| 2024-03-08 | Troendle August J. | director, 10 percent owner, officer: CEO | 4,733,019 | S-Sale | D | 25,000 | 408.71 | 10,217,750.00 |
| 2024-03-06 | Medpace Investors, LLC | 10 percent owner | 4,833,019 | S-Sale | D | 100,000 | 412.98 | 41,298,000.00 |
| 2024-03-07 | Medpace Investors, LLC | 10 percent owner | 4,758,019 | S-Sale | D | 75,000 | 410.74 | 30,805,500.00 |
| 2024-03-08 | Medpace Investors, LLC | 10 percent owner | 4,733,019 | S-Sale | D | 25,000 | 408.71 | 10,217,750.00 |
| 2024-03-07 | Keating Ashley M. | director | 472 | M-Exempt | A | 472 | 54.99 | 25,955.00 |
| 2024-03-07 | Keating Ashley M. | director | 0 | M-Exempt | D | 472 | 54.99 | 25,955.00 |
| 2024-03-07 | Keating Ashley M. | director | 0 | S-Sale | D | 472 | 415.00 | 195,880.00 |
| 2024-03-04 | GEIGER JESSE J | officer: President | 26,145 | M-Exempt | A | 22,321 | 90.65 | 2,023,399.00 |
| 2024-03-05 | GEIGER JESSE J | officer: President | 21,503 | M-Exempt | A | 17,679 | 90.65 | 1,602,601.00 |
| 2024-03-04 | GEIGER JESSE J | officer: President | 17,679 | M-Exempt | D | 22,321 | 90.65 | 2,023,399.00 |
| 2024-03-04 | GEIGER JESSE J | officer: President | 3,824 | S-Sale | D | 22,321 | 403.03 | 8,996,033.00 |
| 2024-03-05 | GEIGER JESSE J | officer: President | 0 | M-Exempt | D | 17,679 | 90.65 | 1,602,601.00 |
| 2024-03-04 | Troendle August J. | director, 10 percent owner, officer: CEO | 4,983,019 | S-Sale | D | 50,000 | 403.12 | 20,156,000.00 |
| 2024-03-05 | Troendle August J. | director, 10 percent owner, officer: CEO | 4,933,019 | S-Sale | D | 50,000 | 402.70 | 20,135,000.00 |
| 2024-03-04 | Medpace Investors, LLC | 10 percent owner | 4,983,019 | S-Sale | D | 50,000 | 403.12 | 20,156,000.00 |
| 2024-03-05 | Medpace Investors, LLC | 10 percent owner | 4,933,019 | S-Sale | D | 50,000 | 402.70 | 20,135,000.00 |
| 2024-02-29 | Medpace Investors, LLC | 10 percent owner | 5,113,019 | S-Sale | D | 20,000 | 393.71 | 7,874,200.00 |
| 2024-03-01 | Medpace Investors, LLC | 10 percent owner | 5,033,019 | S-Sale | D | 80,000 | 401.88 | 32,150,400.00 |
| 2024-02-29 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,113,019 | S-Sale | D | 20,000 | 393.71 | 7,874,200.00 |
| 2024-03-01 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,033,019 | S-Sale | D | 80,000 | 401.88 | 32,150,400.00 |
| 2024-02-29 | EWALD STEPHEN P | officer: General Counsel & Corp. Secy. | 13,691 | S-Sale | D | 1,163 | 393.51 | 457,646.00 |
| 2024-03-01 | EWALD STEPHEN P | officer: General Counsel & Corp. Secy. | 13,341 | S-Sale | D | 350 | 400.79 | 140,276.00 |
| 2024-02-29 | GEIGER JESSE J | officer: President | 3,824 | S-Sale | D | 2,558 | 393.51 | 1,006,586.00 |
| 2024-02-28 | Keating Ashley M. | director | 500 | M-Exempt | A | 500 | 54.99 | 27,495.00 |
| 2024-02-28 | Keating Ashley M. | director | 472 | M-Exempt | D | 500 | 54.99 | 27,495.00 |
| 2024-02-28 | Keating Ashley M. | director | 0 | S-Sale | D | 500 | 405.00 | 202,500.00 |
| 2024-02-27 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,183,019 | S-Sale | D | 50,000 | 401.88 | 20,094,000.00 |
| 2024-02-28 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,133,019 | S-Sale | D | 50,000 | 404.13 | 20,206,500.00 |
| 2024-02-27 | Medpace Investors, LLC | 10 percent owner | 5,183,019 | S-Sale | D | 50,000 | 401.88 | 20,094,000.00 |
| 2024-02-28 | Medpace Investors, LLC | 10 percent owner | 5,133,019 | S-Sale | D | 50,000 | 404.13 | 20,206,500.00 |
| 2024-02-23 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,289,947 | S-Sale | D | 100,000 | 400.32 | 40,032,000.00 |
| 2024-02-26 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,233,019 | S-Sale | D | 56,928 | 402.38 | 22,906,689.00 |
| 2024-02-23 | Medpace Investors, LLC | 10 percent owner | 5,289,947 | S-Sale | D | 100,000 | 400.32 | 40,032,000.00 |
| 2024-02-26 | Medpace Investors, LLC | 10 percent owner | 5,233,019 | S-Sale | D | 56,928 | 402.38 | 22,906,689.00 |
| 2024-02-21 | Medpace Investors, LLC | 10 percent owner | 5,489,947 | S-Sale | D | 36,012 | 383.44 | 13,808,441.00 |
| 2024-02-22 | Medpace Investors, LLC | 10 percent owner | 5,389,947 | S-Sale | D | 100,000 | 395.98 | 39,598,000.00 |
| 2024-02-21 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,489,947 | S-Sale | D | 36,012 | 383.44 | 13,808,441.00 |
| 2024-02-22 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,389,947 | S-Sale | D | 100,000 | 395.98 | 39,598,000.00 |
| 2024-02-20 | Carley Brian T | director | 21,595 | M-Exempt | A | 13,782 | 26.44 | 364,396.00 |
| 2024-02-20 | Carley Brian T | director | 0 | M-Exempt | D | 13,782 | 26.44 | 364,396.00 |
| 2024-02-16 | Medpace Investors, LLC | 10 percent owner | 5,539,947 | S-Sale | D | 50,000 | 391.75 | 19,587,500.00 |
| 2024-02-20 | Medpace Investors, LLC | 10 percent owner | 5,525,959 | S-Sale | D | 13,988 | 386.39 | 5,404,823.00 |
| 2024-02-16 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,539,947 | S-Sale | D | 50,000 | 391.75 | 19,587,500.00 |
| 2024-02-20 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,525,959 | S-Sale | D | 13,988 | 386.39 | 5,404,823.00 |
| 2024-02-08 | McCarthy Cornelius P. III | director | 5,038 | M-Exempt | A | 4,710 | 57.17 | 269,271.00 |
| 2024-02-08 | McCarthy Cornelius P. III | director | 0 | M-Exempt | D | 4,710 | 57.17 | 269,271.00 |
| 2023-12-31 | Kraft Robert O. | director | 376 | M-Exempt | A | 94 | 0.00 | 0.00 |
| 2023-12-31 | Kraft Robert O. | director | 0 | M-Exempt | D | 94 | 0.00 | 0.00 |
| 2023-12-31 | McCarthy Cornelius P. III | director | 328 | M-Exempt | A | 82 | 0.00 | 0.00 |
| 2023-12-31 | McCarthy Cornelius P. III | director | 0 | M-Exempt | D | 82 | 0.00 | 0.00 |
| 2023-12-31 | Carley Brian T | director | 7,813 | M-Exempt | A | 103 | 0.00 | 0.00 |
| 2023-12-31 | Carley Brian T | director | 0 | M-Exempt | D | 103 | 0.00 | 0.00 |
| 2023-12-14 | BURWIG SUSAN E | officer: Exec. VP, Operations | 17,292 | S-Sale | D | 10,391 | 304.15 | 3,160,423.00 |
| 2023-12-15 | BURWIG SUSAN E | officer: Exec. VP, Operations | 15,283 | S-Sale | D | 2,009 | 303.00 | 608,727.00 |
| 2023-11-30 | McCarthy Cornelius P. III | director | 249 | A-Award | A | 249 | 0.00 | 0.00 |
| 2023-11-30 | Kraft Robert O. | director | 286 | A-Award | A | 286 | 0.00 | 0.00 |
| 2023-11-30 | Carley Brian T | director | 313 | A-Award | A | 313 | 0.00 | 0.00 |
| 2023-11-29 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,639,947 | S-Sale | D | 3,167 | 272.87 | 864,179.00 |
| 2023-11-29 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,621,857 | S-Sale | D | 18,090 | 272.62 | 4,931,696.00 |
| 2023-11-30 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,613,986 | S-Sale | D | 7,871 | 272.18 | 2,142,329.00 |
| 2023-12-01 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,589,947 | S-Sale | D | 24,039 | 273.26 | 6,568,897.00 |
| 2023-11-29 | Medpace Investors, LLC | 10 percent owner | 5,639,947 | S-Sale | D | 3,167 | 272.87 | 864,179.00 |
| 2023-11-29 | Medpace Investors, LLC | 10 percent owner | 5,621,857 | S-Sale | D | 18,090 | 272.62 | 4,931,696.00 |
| 2023-11-30 | Medpace Investors, LLC | 10 percent owner | 5,613,986 | S-Sale | D | 7,871 | 272.18 | 2,142,329.00 |
| 2023-12-01 | Medpace Investors, LLC | 10 percent owner | 5,589,947 | S-Sale | D | 24,039 | 273.26 | 6,568,897.00 |
| 2023-11-27 | Medpace Investors, LLC | 10 percent owner | 5,664,947 | S-Sale | D | 25,000 | 276.10 | 6,902,500.00 |
| 2023-11-28 | Medpace Investors, LLC | 10 percent owner | 5,643,114 | S-Sale | D | 21,833 | 273.66 | 5,974,819.00 |
| 2023-11-27 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,664,947 | S-Sale | D | 25,000 | 276.10 | 6,902,500.00 |
| 2023-11-28 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,643,114 | S-Sale | D | 21,833 | 273.66 | 5,974,819.00 |
| 2023-11-22 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,689,947 | S-Sale | D | 25,000 | 277.81 | 6,945,250.00 |
| 2023-11-22 | Medpace Investors, LLC | 10 percent owner | 5,689,947 | S-Sale | D | 25,000 | 277.81 | 6,945,250.00 |
| 2023-11-21 | Medpace Investors, LLC | 10 percent owner | 5,714,947 | S-Sale | D | 25,000 | 277.37 | 6,934,250.00 |
| 2023-11-21 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,714,947 | S-Sale | D | 25,000 | 277.37 | 6,934,250.00 |
| 2023-11-17 | Medpace Investors, LLC | 10 percent owner | 5,789,947 | S-Sale | D | 50,000 | 273.91 | 13,695,500.00 |
| 2023-11-20 | Medpace Investors, LLC | 10 percent owner | 5,739,947 | S-Sale | D | 50,000 | 275.45 | 13,772,500.00 |
| 2023-11-17 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,789,947 | S-Sale | D | 50,000 | 273.91 | 13,695,500.00 |
| 2023-11-20 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,739,947 | S-Sale | D | 50,000 | 275.45 | 13,772,500.00 |
| 2023-11-14 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,889,947 | S-Sale | D | 25,000 | 283.11 | 7,077,750.00 |
| 2023-11-15 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,856,947 | S-Sale | D | 33,000 | 283.42 | 9,352,860.00 |
| 2023-11-16 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,839,947 | S-Sale | D | 17,000 | 281.61 | 4,787,370.00 |
| 2023-11-14 | Medpace Investors, LLC | 10 percent owner | 5,889,947 | S-Sale | D | 25,000 | 283.11 | 7,077,750.00 |
| 2023-11-15 | Medpace Investors, LLC | 10 percent owner | 5,856,947 | S-Sale | D | 33,000 | 283.42 | 9,352,860.00 |
| 2023-11-16 | Medpace Investors, LLC | 10 percent owner | 5,839,947 | S-Sale | D | 17,000 | 281.61 | 4,787,370.00 |
| 2023-10-23 | BURWIG SUSAN E | officer: Exec. VP, Operations | 27,683 | M-Exempt | A | 7,500 | 32.05 | 240,375.00 |
| 2023-10-23 | BURWIG SUSAN E | officer: Exec. VP, Operations | 7,500 | M-Exempt | D | 7,500 | 32.05 | 240,375.00 |
| 2023-09-30 | Carley Brian T | director | 7,710 | M-Exempt | A | 103 | 0.00 | 0.00 |
| 2023-09-30 | Carley Brian T | director | 103 | M-Exempt | D | 103 | 0.00 | 0.00 |
| 2023-09-30 | Kraft Robert O. | director | 282 | M-Exempt | A | 94 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
